<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04255524</url>
  </required_header>
  <id_info>
    <org_study_id>OCTAPPA</org_study_id>
    <nct_id>NCT04255524</nct_id>
  </id_info>
  <brief_title>Choroidal Change on OCTA in Eyes With High Myopia</brief_title>
  <official_title>OCTA to Quantify the Parapapillary Choroidal Microvascular Changes in High Myopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myopia is a global healthy concern, especially the high myopia and pathological myopia among
      Asian populations. However, its mechanism still remains largely unclear. Recent findings
      suggested choroidal changes might be related to the development of myopia. This study is to
      useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in
      myopic eyes, and try to find the cause-and-effect relationship between choroidal change and
      the development of myopia.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parapapillary choroidal microvasculature void (MvV) area</measure>
    <time_frame>changes of MvV area from at 10 years</time_frame>
    <description>area of parapapillary choroidal microvasculature void on OCTA images</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parapapillary choroidal microvasculature void (MvV) area</measure>
    <time_frame>difference of MvV area in each group at baseline</time_frame>
    <description>area of parapapillary choroidal microvasculature void on OCTA images</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parapapillary choroidal microvasculature void (MvV) area</measure>
    <time_frame>changes of MvV area at 1 years</time_frame>
    <description>area of parapapillary choroidal microvasculature void on OCTA images</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parapapillary choroidal microvasculature void (MvV) area</measure>
    <time_frame>changes of MvV area at 3 years</time_frame>
    <description>area of parapapillary choroidal microvasculature void on OCTA images</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parapapillary choroidal microvasculature void (MvV) area</measure>
    <time_frame>changes of MvV area at 5 years</time_frame>
    <description>area of parapapillary choroidal microvasculature void on OCTA images</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MvV number</measure>
    <time_frame>baseline</time_frame>
    <description>number of choroidal MvV with certain size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and refractive power</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and refractive power</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and PPA area</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and parapapillary atrophy beta area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and choroid thickness</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and choroid thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and RNFL thickness</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and RNFL thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and Axial length</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and Axial length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and retinal parapapillary perfusion</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and retinal parapapillary perfusion on OCTA images.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation coefficient between choroidal MvV and Macular perfusion</measure>
    <time_frame>baseline</time_frame>
    <description>Correlation coefficient between choroidal MvV and Macular perfusion on OCTA images, Retinal parapapillary perfusion with OCTA.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Myopia, Progressive</condition>
  <condition>Choroid Disease</condition>
  <arm_group>
    <arm_group_label>Group 1/Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spherical equivalent: -2.00～+2.00 D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 1/Myopia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spherical equivalent: -3.00～-6.00 D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3/High</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spherical equivalent: -6.00～-10.00 D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4/Super High</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spherical equivalent: &lt;-10.00</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optic coherence tomography angiography (OCTA)</intervention_name>
    <description>Using non-invasive, repeatable, mature device OCTA to obtain choroidal angio-map</description>
    <arm_group_label>Group 1/Control</arm_group_label>
    <arm_group_label>Group 1/Myopia</arm_group_label>
    <arm_group_label>Group 3/High</arm_group_label>
    <arm_group_label>Group 4/Super High</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Spherical equivalent measurement can be included in above 4 groups

          2. Willing to be followed up in the future 10 years

        Exclusion Criteria:

          1. Deny to sign the patient consent, or deny to be followed

          2. Evidence of cardiac, or diabetic, or CNS disease.

          3. Clinically diagnosed with retinal or choroidal disease

          4. Glucoma

          5. Cataract or corneal disease that influence the quality of fundus OCTA image
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zizong Hu, PhD, MD</last_name>
    <phone>+8615195960100</phone>
    <email>huzizhong@njum.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qinghuai Liu, PhD, MD</last_name>
    <phone>+8615195960100</phone>
    <email>liuqh@njmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>February 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>February 2, 2020</last_update_submitted>
  <last_update_submitted_qc>February 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OCTA</keyword>
  <keyword>Myopia</keyword>
  <keyword>Choroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Myopia, Degenerative</mesh_term>
    <mesh_term>Choroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>After completion of the prospective observational study, we would like to share data for reasonable request from other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

